Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 104
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
Phase III, Phase II
CLBH589B2201
NCT00425555
Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma
Phase III, Phase II
CLBH589B2212
NCT00490776
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Phase III
Hx-CD4-110
NCT00127881
Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
Phase II, Phase I
MSKCC-95024
NCI-V95-0685, NCT00002663
Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
Phase II, Phase I
NCI-97-C-0110Q
NCT00019305
Alemtuzumab Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Mycosis Fungoides/Sezary Syndrome
Phase II, Phase I
NHLBI-02-H-0250
NCT00047060
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Phase II, Phase I
Derm 446
NCT00129415
Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
Phase II, Phase I
LYMNHL0014
80057, LYMNHL0014, NCT00185965, NIH, NCT00185965
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Phase II, Phase I
NU-05H8
NU-0310-101, LILLY-NU-05H8, NCT00369629
Chemotherapy, Donor Stem Cell Transplant, and Graft-Versus-Host Disease Prevention in Treating Patients With Advanced Hematologic Cancer or Other Disease
Phase II, Phase I
NCI-07-C-0195
07-C-0195, NCT00520130
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute